These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16859643)
1. Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Lee HY; Jo SH; Lee C; Baek SH; Bae YS Biochem Pharmacol; 2006 Sep; 72(7):860-8. PubMed ID: 16859643 [TBL] [Abstract][Full Text] [Related]
2. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210 [TBL] [Abstract][Full Text] [Related]
3. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291 [TBL] [Abstract][Full Text] [Related]
4. Differential activation of formyl peptide receptor-like 1 by peptide ligands. Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886 [TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Lee HY; Kim MK; Park KS; Bae YH; Yun J; Park JI; Kwak JY; Bae YS Biochem Biophys Res Commun; 2005 May; 330(3):989-98. PubMed ID: 15809093 [TBL] [Abstract][Full Text] [Related]
6. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2. Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism. Christman BW; Christman JW; Dworski R; Blair IA; Prakash C J Immunol; 1993 Aug; 151(4):2096-104. PubMed ID: 8393898 [TBL] [Abstract][Full Text] [Related]
8. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Karlsson J; Fu H; Boulay F; Bylund J; Dahlgren C Biochem Pharmacol; 2006 May; 71(10):1488-96. PubMed ID: 16549058 [TBL] [Abstract][Full Text] [Related]
9. Activation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide. Jo EJ; Lee HY; Kim JI; Kang HK; Lee YN; Kwak JY; Bae YS Life Sci; 2004 Sep; 75(18):2217-32. PubMed ID: 15325847 [TBL] [Abstract][Full Text] [Related]
10. Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. Bae YS; Kim Y; Kim JH; Lee TG; Suh PG; Ryu SH J Immunol; 2000 Apr; 164(8):4089-96. PubMed ID: 10754302 [TBL] [Abstract][Full Text] [Related]
11. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256 [TBL] [Abstract][Full Text] [Related]
12. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823 [TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. Björkman L; Karlsson J; Karlsson A; Rabiet MJ; Boulay F; Fu H; Bylund J; Dahlgren C J Leukoc Biol; 2008 Feb; 83(2):245-53. PubMed ID: 17984291 [TBL] [Abstract][Full Text] [Related]
15. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events. Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194 [TBL] [Abstract][Full Text] [Related]
16. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077 [TBL] [Abstract][Full Text] [Related]
17. A novel nonpeptide ligand for formyl peptide receptor-like 1. Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762 [TBL] [Abstract][Full Text] [Related]
18. Group IB secretory phospholipase A2 stimulates leukotriene B4 production by a unique mechanism in human neutrophils. Lee HY; Kim MK; Park KS; Shin EH; Bae YS Biochem Biophys Res Commun; 2005 Aug; 334(2):500-8. PubMed ID: 16005851 [TBL] [Abstract][Full Text] [Related]
19. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. Kang HK; Lee HY; Kim MK; Park KS; Park YM; Kwak JY; Bae YS J Immunol; 2005 Jul; 175(2):685-92. PubMed ID: 16002663 [TBL] [Abstract][Full Text] [Related]
20. Differential activation of formyl peptide receptor signaling by peptide ligands. Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]